Portola?s long-acting blood thinner misses main goal in study
 

Portola?s long-acting blood thinner misses main goal in study
(Reuters) - Portola Pharmaceuticals Inc said late-stage data showed its oral anticoagulant was **t superior to an injectable standard therapy in preventing blood clots in acutely ill patients.


http://rc.feedsportal.com/r/24739583...14/rc/1/rc.img

http://rc.feedsportal.com/r/24739583...14/rc/2/rc.img

http://rc.feedsportal.com/r/24739583...14/rc/3/rc.img

http://da.feedsportal.com/r/24739583...f/sc/14/a2.img
http://adchoice.feedsportal.com/r/24.../sc/14/ach.imghttp://pi.feedsportal.com/r/24739583.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2473958...sc/14/a2t2.imghttp://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...LY:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...LY:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/xOLux8b3y2Y